Safety and Efficacy of PG101 for Dry Eye Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
To evaluate the safety and efficacy of 0.25% PG101 and 1.0% PG101 topical gel suspension compared to placebo when administered two times daily for 14 days in subjects diagnosed with dry eye syndrome
Epistemonikos ID: 57c9f0d99125ddae41ddb3484decaca9bc86629a
First added on: May 11, 2024